Objective: To compare the pharmacokinetic profile and bioavailability of budesonide after inhalation from the Clickhaler® dry powder inhaler with the Turbuhaler® as standard. Design: Randomised, ...

April 5, 2005 — The European Commission has approved for use in the European Union a second-generation embolic protection system for use in saphenous vein graft interventional procedures; the Japanese ...

Recipharm AB has announced that it is working with Vectura Group plc to provide access to its license for the regulatory dossier of Asmasal® for the Chinese regulatory authorities as part of the ...

U.K.-owned Vectura Group said today it formed a RMB 400 million ($65 million) joint venture with two Chinese partners aimed at commercializing new respiratory products in China and the rest of Asia.

Merck KGaA of Germany has set up a dedicated business to tap into the fast-growing market for respiratory drugs. Part of Merck Generics, the unit will focus on developing new respiratory drugs for ...